83 Tumor immune microenvironment characterization from pre- and post-dose tumors collected from a phase 1/2 study of NDI-101150, a hematopoietic progenitor kinase 1 (HPK1) inhibitor

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Regular and Young Investigator Award Abstracts

Topics

Biology

Cancer Oncology

Medicine

Immunology

Cancer Research

Show all topics

DOI

10.1136/jitc-2024-sitc2024.0083

License

CC-BY-NC

Other Formats

PDF